REBECCA THERIOT: Open Payments
NPI 1730431297 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 12 payments from 8 companies in 2025. Trend: 2023 $1,608 · 2024 $366 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Lundbeck LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ABBVIE INC. | 1 | $20 |
| Corium, LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
Products named: REXULTI, FANAPT, VRAYLAR, Azstarys, CAPLYTA, XIFAXAN, Heplisav-B.
Industry payments across LA — which companies pay providers there.
